Global High Content Screening Products Market: Overview
The report on the global high content screening products market
factors in every possible driver and restraint shaping the trajectory
of the market. It studies all such trends in-depth. It also segments the
market based on different parameters and examines each segment
thoroughly to uncover where the opportunity lies in the market. This is
to help readers gather a proper idea of the market’s hierarchy and thus
understand which segments to invest in.
The geographical analysis of the high
content screening products market provided in the report also tries to
educate savvy market players about the best regions to invest in. The
report also sheds light on the competitive dynamics prevailing in the
market. To do so, it leverages market leading analytical tools such a
Porter’s Five Forces and SWOT Analysis. Such methods helps to gauge the
opportunities and threats the market presents.
As per Transparency Market Research, the
global high content screening market will likely rise at a CAGR of 8.0%
from 2017 to 2022 to become worth US$1.23 bn by 2022.
Global High Content Screening Products Market: Dynamics
The report discusses the various drivers
affecting the growth of the global high content screening products
market. It finds that regulatory factors play a key role in stoking
growth. For example government support for cell-based research for
creating new and more effective drugs for various diseases has been
providing a fillip to the market.
The report glances at various other
prevailing diseases that have provided a boost to the market. Companies
wanting to bolster their positions in the global high content screening
products market need to keep in mind such growth drivers to take
advantage for the opportunities. The report provides readers with
detailed analysis of which factors are likely to have a lasting
impression on the global high content screening products market in the
coming years.
Global High Content Screening Products Market: Segmentation
The report studies the segmentation of
the global high content screening products market. It assesses the
leading segments in the market to understand their impact on the global
market’s dynamics. Consumables, microplates, instruments, software, and
service are the different types high content screening products
available in the market. At present the consumables dominates the market
with maximum share and are predicted to clock a healthy CAGR of 8.3% in
the forecast period to become worth US$486.6 mn in 2022. The high
screening instruments too account for a substantial share in the market
because of their cost effectiveness owing to the use of LED light
engines that brings down the intensity of fluctuations and hence negates
the need to switch to external illuminating sources.
Among the regional markets, North America
runs the show with most of the share in the global high content
screening products market. Increasing prevalence of chronic diseases, a
considerable population of elderly, rising collaborations of research
institutes, carefully-considered mergers and acquisitions between
companies, and an advanced healthcare infrastructure are some of the
factors majorly fuelling the market in the region. The market in the
region is predicted to clock a healthy 8.2% CAGR between 2017 and 2022.
Rising at this pace it is expected to attain a value of US$402.1 mn in
2022.
Global High Content Screening Products Market: Competitive Dynamics
Thermo Fisher Scientific, Molecular
Devices, GE Healthcare, PerkinElmer Inc., Becton, Dickinson and Company,
Thorlabs, Inc., Merck KGaA, Cell Signaling Technology, Genedata AG, and
Yokogawa Electric Corporation are to name a few key players operating
in the global high content screening products market.
No comments:
Post a Comment